subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009

object_name: gastric cancer

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:135402009

object_name: stage IV esophageal cancer


subject: PUBCHEM.COMPOUND:135402009

object_name: gastroesophageal cancer


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Stomach cancer


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: UNII:L26E95NLRK

subject_name: CUSTIRSEN

object_name: cancer


subject: UNII:L26E95NLRK

object_name: neoplasm


subject: CHEBI:31355

subject_name: Carboplatin

tested_intervention: yes


subject: CHEBI:31355


subject: CHEBI:23080

subject_name: cerotoyl group

object_name: colorectal adenocarcinoma


subject: PR:000015192

subject_name: sodium- and chloride-dependent creatine transporter 1


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: plasma cell neoplasm


subject: CHEBI:34954

subject_name: (S)-ropivacaine hydrochloride hydrate

object_name: osteoarthritis, hip


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: oropharyngeal carcinoma


subject: CHEBI:4026

object_name: oropharynx cancer


subject: CHEBI:4026

object_name: Stage IV Oropharyngeal Carcinoma


subject: CHEBI:4026

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:4026

object_name: Refractory Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: Head and neck cancer metastatic


subject: CHEBI:4026

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:4026

object_name: human papillomavirus-related squamous cell carcinoma


subject: CHEBI:4026

object_name: Neck Carcinoma


subject: CHEBI:4026

object_name: head and neck neoplasm


subject: CHEBI:4026

object_name: head and neck cancer


subject: CHEBI:4026

object_name: Human Papillomavirus-Related Mucosal Head and Neck Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: head and neck squamous cell carcinoma


subject: CHEBI:4026

object_name: Human Papilloma Virus, Female


subject: CHEBI:4026

object_name: Human Papilloma Virus, Male


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: glomerulonephritis


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: end stage renal failure


subject: CHEBI:8228

object_name: Chronic uremia


subject: UMLS:C2933913

object_name: Parkinson disease


subject: UMLS:C5774009

object_name: Blood Clot


subject: UMLS:C5774009

object_name: thrombosis


subject: UMLS:C5774009

object_name: Thrombosis of blood vessel


subject: DRUGBANK:DB11097

subject_name: Plantago seed

object_name: Constipation


subject: DRUGBANK:DB11097

object_name: Constipation, CTCAE


subject: CHEBI:165446

subject_name: Psyllic acid


subject: CHEBI:165446


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate

object_name: Toxicity due to chemotherapy


subject: PUBCHEM.COMPOUND:254731


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: colorectal neoplasm


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C2703114


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:36791

subject_name: Escitalopram

object_name: borderline personality disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: DRUGBANK:DB13975

subject_name: Black cohosh

object_name: Sexual Orientation


subject: UNII:RC2V4W0EYC

subject_name: Buloxibutid

object_name: preeclampsia postpartum


subject: CHEBI:138409


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: cystic fibrosis


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:66901

subject_name: Ivacaftor


subject: CHEBI:90951

subject_name: Lumacaftor


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:31348

subject_name: Capecitabine

object_name: carcinoma of biliary tract


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:119915

subject_name: Fentanyl

object_name: prostate cancer


subject: CHEBI:119915

object_name: Surgical procedure finding


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: UMLS:C4683552


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: acute leukemia


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: atrial fibrillation


subject: UMLS:C3854029

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C3854029

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: fetal cytomegalovirus syndrome


subject: UNII:VYR5R5XN5A

subject_name: LUNSEKIMIG

object_name: asthma


subject: UMLS:C5909039

subject_name: Lunsekimig


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: glioblastoma


subject: DRUGBANK:DB15803

object_name: Childhood Glioblastoma


subject: DRUGBANK:DB15803

object_name: adult glioblastoma


subject: CHEBI:70707

subject_name: Vilazodone

object_name: endogenous depression


subject: CHEBI:70707

object_name: major depressive disorder


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: neurodevelopmental disorder


subject: UMLS:C0813973

object_name: epilepsy


subject: UMLS:C0813973

object_name: cancer


subject: UMLS:C0813973

object_name: neoplasm


subject: UNII:9MM2R1A06R

object_name: Childhood Breast Carcinoma


subject: UNII:9MM2R1A06R

object_name: breast carcinoma


subject: UNII:9MM2R1A06R

object_name: breast cancer


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:71940

subject_name: Tadalafil

object_name: heart failure


subject: CHEBI:71940

object_name: Heart Failure, CTCAE


subject: CHEBI:71940

object_name: pulmonary hypertension


subject: CHEBI:71940

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Solid Neoplasm


subject: CHEBI:62880

subject_name: Veliparib

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:62880

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: biliary tract cancer


subject: CHEBI:175901

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: MESH:C079198

subject_name: S 1 (combination)


subject: MESH:C079198


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pancreatic neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: exocrine pancreatic carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: malignant pancreatic neoplasm


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:114785

subject_name: Erlotinib

object_name: squamous cell carcinoma


subject: CHEBI:4875

subject_name: Etanercept

object_name: rheumatoid arthritis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:177762

subject_name: Alovudine

object_name: adult lymphoma


subject: CHEBI:177762

object_name: lymphoma


subject: CHEBI:177762

object_name: pediatric lymphoma


subject: CHEBI:177762

object_name: diffuse large B-cell lymphoma


subject: CHEBI:177762

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:177762

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:177762

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:177762

object_name: non-Hodgkin lymphoma


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: CHEBI:177770

subject_name: Ganetespib


subject: PUBCHEM.COMPOUND:121371196

subject_name: Limertinib

object_name: PD-L1 Overexpression


subject: PUBCHEM.COMPOUND:121371196

object_name: PD-L1 Positive


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C0592544

subject_name: Zomacton

object_name: Congenital IGHD


subject: UMLS:C0592544

object_name: Reduced circulating growth hormone concentration


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: sinusitis


subject: UNII:2P471X1Z11

object_name: Sinusitis, CTCAE


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEMBL.COMPOUND:CHEMBL2108348

subject_name: NONACOG BETA PEGOL

object_name: hemophilia B


subject: CHEMBL.COMPOUND:CHEMBL2108348

object_name: Congenital Bleeding Disorder


subject: CHEMBL.COMPOUND:CHEMBL2109205

subject_name: nonacog alfa


subject: CHEMBL.COMPOUND:CHEMBL2109205


subject: UMLS:C3883805

subject_name: coagulation factor IX (recombinant), glycopegylated


subject: UMLS:C3883805


subject: CHEBI:147398

subject_name: Tideglusib

object_name: Alzheimer disease


subject: UMLS:C1957846


subject: CHEBI:78538

object_name: Transthyretin cardiac amyloidosis


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Right-sided colon cancer


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C0771948

subject_name: Fosfomycin sodium


subject: CHEMBL.COMPOUND:CHEMBL2109390

object_name: glioma


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:22976653

object_name: cerebrovascular disorder


subject: PUBCHEM.COMPOUND:22976653

object_name: Stroke (heart beat)


subject: PUBCHEM.COMPOUND:22976653

object_name: Stroke, CTCAE


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: CHEBI:9150

subject_name: Simvastatin

object_name: colorectal cancer


subject: CHEBI:9150

object_name: colorectal carcinoma


subject: CHEBI:9150

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: rheumatoid arthritis


subject: CHEBI:60072

subject_name: Erythrityl tetranitrate


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: UMLS:C5854424

subject_name: CLK Inhibitor CTX-712

object_name: Myelodysplasia


subject: UMLS:C5854424

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5854424

object_name: acute myeloid leukemia


subject: UMLS:C3529756

subject_name: bendavia

object_name: Reperfusion Injury


subject: UMLS:C3529756

object_name: renal artery obstruction


subject: UMLS:C3529756

object_name: renovascular hypertension


subject: UNII:EPZ68T461K

object_name: Alzheimer disease type 1


subject: UNII:EPZ68T461K

object_name: Alzheimer disease


subject: MESH:C000634366


subject: MESH:C000634366


subject: CHEBI:94534

subject_name: olanzapine

object_name: alcohol abuse


subject: CHEBI:94534

object_name: alcohol dependence


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: Peptic Ulcer


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:15365

subject_name: Aspirin


subject: PR:000004321

subject_name: arylsulfatase A


subject: UMLS:C4699675

subject_name: Esomeprazole (Nexium)


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:90217

subject_name: Quizartinib

object_name: leukemia


subject: CHEBI:90217

object_name: childhood leukemia


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:75922

subject_name: Nepafenac

object_name: wet macular degeneration


subject: CHEBI:75922

object_name: retinal vein occlusion


subject: CHEBI:75922

object_name: diabetic macular edema


subject: UMLS:C1707756

subject_name: Alcon


subject: UMLS:C1707756


subject: UMLS:C1707756


subject: CHEBI:44915

subject_name: Propofol

object_name: Drug Interactions


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Menorrhagia


subject: CHEBI:3360

subject_name: Cannabinol

object_name: Safety Issues


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: neoplasm


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C2703114


subject: CHEBI:52717

subject_name: Bortezomib

object_name: chronic graft versus host disease


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: asphyxia


subject: CHEBI:17650

object_name: perinatal asphyxia


subject: CHEBI:17650

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:17650

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:17650

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: GTOPDB:4985

object_name: melanoma


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UMLS:C0021735

subject_name: Viraferon


subject: CHEBI:63637

subject_name: Vemurafenib


subject: UMLS:C2981819

object_name: Childhood Solid Neoplasm


subject: UMLS:C2981819

object_name: Adult Solid Neoplasm


subject: UMLS:C2981819

object_name: Solid Neoplasm


subject: UMLS:C2981819

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63451

subject_name: Infigratinib


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: bronchiolitis obliterans syndrome


subject: CHEBI:3732

object_name: Acute obliterating bronchiolitis


subject: UMLS:C3885146

subject_name: olokizumab

object_name: arthritis


subject: UMLS:C3885146

object_name: Arthritis, CTCAE


subject: UMLS:C3885146

object_name: rheumatoid arthritis


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:231614

subject_name: Nivolumab

object_name: metastatic colorectal cancer


subject: UMLS:C2346820


subject: CHEBI:75179

subject_name: Trifluridine


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: multiple sclerosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:31902

subject_name: Nicergoline

object_name: Dysphagia


subject: CHEBI:31902

object_name: Dysphagia, CTCAE


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest

object_name: endometriosis


subject: CHEBI:131156


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: chronic hepatitis B virus infection


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:31781

subject_name: Lopinavir

object_name: Pregnant


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:125628

subject_name: Alisertib

object_name: Childhood Breast Carcinoma


subject: CHEBI:125628

object_name: breast carcinoma


subject: CHEBI:125628

object_name: breast cancer


subject: CHEBI:125628

object_name: breast neoplasm


subject: CHEBI:125628

object_name: Malignant melanoma of skin of breast


subject: CHEBI:145374

subject_name: Enasidenib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:145374

object_name: acute myeloid leukemia


subject: CHEBI:37956

subject_name: histamine antagonist


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: UMLS:C0003209

subject_name: Anti-Inflammatory Agents


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: UMLS:C0354604

subject_name: oral anticoagulants


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: sciatica


subject: CHEBI:135207

subject_name: Clofedanol

object_name: prostate carcinoma


subject: CHEBI:135207

object_name: prostate cancer


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:39548


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: liver neoplasm


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C2703114


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Tumor Mass


subject: CHEBI:31355

object_name: uterine disease


subject: CHEBI:31355

object_name: cervix disorder


subject: CHEBI:31355

object_name: ovarian carcinoma


subject: CHEBI:31355

object_name: malignant epithelial tumor of ovary


subject: CHEBI:31355

object_name: primary peritoneal carcinoma


subject: CHEBI:31355

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:31355

object_name: peritoneal carcinoma


subject: CHEBI:31355

object_name: ovarian neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:71219

subject_name: Pazopanib

object_name: cancer


subject: CHEBI:71219

object_name: neoplasm


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: CHEBI:36796

subject_name: duloxetine

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:31355

object_name: Her2-receptor negative breast cancer


subject: CHEBI:31355

object_name: Malignant neoplasm of female breast


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:49040

object_name: metabolic syndrome X


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: PUBCHEM.COMPOUND:9832423

subject_name: Vytorin


subject: PUBCHEM.COMPOUND:9832423


subject: RXCUI:476348

subject_name: ezetimibe / simvastatin Oral Tablet


subject: RXCUI:476348


subject: CHEBI:9123

subject_name: Sertraline

object_name: Depressed mood


subject: CHEBI:9123

object_name: Cancer patients and suicide and depression


subject: CHEBI:9123

object_name: Depressed - symptom


subject: CHEBI:9123

object_name: Depression, CTCAE


subject: CHEBI:9123

object_name: Chest pain


subject: CHEBI:9123

object_name: Panic attack


subject: CHEBI:114785

subject_name: Erlotinib

object_name: classic familial adenomatous polyposis


subject: CHEBI:114785

object_name: Adenomatous colonic polyposis


subject: CHEBI:114785

object_name: attenuated familial adenomatous polyposis


subject: CHEBI:114785

object_name: non-small cell lung carcinoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: plasma cell myeloma


subject: CHEBI:16480

subject_name: Nitric Oxide


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: Postmenopausal


subject: UNII:3VHF2ZD92J

object_name: Osteopenia


subject: CHEBI:91400

subject_name: Afatinib

object_name: head and neck neoplasm


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: gestational diabetes


subject: UMLS:C3714501

object_name: pregnancy related


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:6121

subject_name: Ketamine

object_name: Insufficient Anesthesia


subject: CHEBI:44915

subject_name: Propofol


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: neuromyelitis optica


subject: UNII:O8M467C50G

subject_name: Vesatolimod

object_name: HIV-1 infection


subject: UMLS:C4764354

subject_name: Niagen

object_name: type 2 diabetes mellitus


subject: UMLS:C4764354

object_name: Overweight and obesity


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: metastatic malignant neoplasm in the lymph nodes


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UMLS:C2343216

subject_name: maca root

object_name: sexual disorder


subject: UMLS:C2343216

object_name: physiological sexual disorder


subject: UMLS:C2343216

object_name: Depressed mood


subject: UMLS:C2343216

object_name: Cancer patients and suicide and depression


subject: UMLS:C2343216

object_name: Depressed - symptom


subject: UMLS:C2343216

object_name: Depression, CTCAE


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:71219

subject_name: Pazopanib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:71219

object_name: acute myeloid leukemia


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: chronic rhinosinusitis with nasal polyps


subject: UMLS:C3658854


subject: PUBCHEM.COMPOUND:11422859

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:11422859

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:11422859

object_name: myoclonic dystonia 11


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Diminished mental health


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: inborn error of immunity


subject: UNII:M09BUF90C0

subject_name: Elvucitabine

object_name: HIV infection


subject: UNII:47DD4548PB

subject_name: Naquotinib

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: inflammatory bowel disease


subject: PUBCHEM.COMPOUND:5281767

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:5281767

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:5281767

object_name: inflammatory bowel disease 1


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Neck Carcinoma


subject: CHEBI:41423

object_name: head and neck neoplasm


subject: CHEBI:41423

object_name: head and neck cancer


subject: CHEBI:41423

object_name: precancerous condition


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: Hormone receptor positive breast cancer


subject: UMLS:C3540795

object_name: hormone receptor-positive breast cancer


subject: UMLS:C3540795

object_name: Carcinoma breast stage IV


subject: CHEBI:27732

subject_name: Caffeine

object_name: Post-Operative Pain


subject: CHEBI:27732

object_name: tooth disorder


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: lung cancer


subject: UNII:PQX0D8J21J

object_name: lung neoplasm


subject: UNII:PQX0D8J21J

object_name: lung carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: PUBCHEM.COMPOUND:74981710

subject_name: Bromelain


subject: PUBCHEM.COMPOUND:74981710

object_name: Malignant neoplasm of female breast


subject: UMLS:C0006217

subject_name: bromelains


subject: UMLS:C0006217


subject: UMLS:C0293742

subject_name: stem bromelain


subject: UMLS:C0293742


subject: DRUGBANK:DB14256

subject_name: Centella asiatica


subject: DRUGBANK:DB14256


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: UNII:NY0COC51FI

subject_name: Tradipitant

object_name: Gastroparesis due to diabetes mellitus


subject: UNII:NY0COC51FI

object_name: gastroparesis


subject: UNII:NY0COC51FI

object_name: Gastroparesis, CTCAE


subject: UNII:NY0COC51FI

object_name: idiopathic gastroparesis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Klatskin Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: bile duct carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: bile duct cancer


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:85995

subject_name: lenvatinib mesylate

object_name: Recurrent Endometrial Cancer


subject: CHEBI:85995

object_name: Recurrent ovarian cancer


subject: CHEBI:85995

object_name: primary peritoneal carcinoma


subject: CHEBI:85995

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:85995

object_name: peritoneal carcinoma


subject: CHEBI:85995

object_name: fallopian tube carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C2826625

subject_name: Fentanyl Citrate Buccal Tablet

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C2826625

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C2826625

object_name: Malignant Solid Neoplasm


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Breast neoplasm female


subject: CHEBI:50790

object_name: Arthralgia


subject: CHEBI:50790

object_name: Arthralgia, CTCAE


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: CHEBI:72296

subject_name: Apixaban

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:72296

object_name: Deep venous thrombosis


subject: CHEBI:72296

object_name: Cerebral Venous Thrombosis Related to COVID-19


subject: CHEBI:72296

object_name: Cerebral venous thrombosis


subject: CHEBI:72296

object_name: Splanchnic vein thrombosis


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:72296


subject: CHEBI:72296

object_name: pulmonary embolism


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan

object_name: triple-negative breast carcinoma


subject: GTOPDB:13304

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:13304

object_name: non-small cell lung carcinoma


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: UMLS:C4726586


subject: CHEBI:63632

subject_name: Topotecan

object_name: retinoblastoma


subject: CHEBI:7459

subject_name: Naloxone

object_name: chronic obstructive pulmonary disease


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: post-traumatic stress disorder


subject: CHEBI:16581

object_name: endogenous depression


subject: CHEBI:16581

object_name: major depressive disorder


subject: UMLS:C2608262

subject_name: Lubricant Eye Drops

object_name: Recurrent ovarian cancer


subject: UNII:98DE7VN88D

subject_name: huMov 19


subject: UMLS:C3640818


subject: CHEBI:9434

subject_name: Telmisartan

object_name: hypertension


subject: CHEBI:9434

object_name: Hypertension, CTCAE


subject: CHEBI:91899

object_name: asthma


subject: CHEBI:3207

subject_name: Budesonide


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: breast cancer


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: MESH:C525703

subject_name: MenACWY

object_name: meningococcal infection


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Alzheimer disease type 1


subject: CHEBI:16822

object_name: Alzheimer disease


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:15354


subject: CHEBI:33325

subject_name: radium atom

object_name: prostate cancer


subject: CHEBI:33325

object_name: prostate neoplasm


subject: UMLS:C3827153


subject: UMLS:C3827153


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: leukemia


subject: UNII:3A189DH42V

object_name: childhood leukemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:2QD3F58224

object_name: hepatitis C


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:3H8GSZ4SQL

object_name: aplastic anemia


subject: UNII:3H8GSZ4SQL

object_name: idiopathic aplastic anemia


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: UMLS:C5446895

subject_name: Anti-CTLA-4 Monoclonal Antibody IBI310

object_name: neuroendocrine neoplasm


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: CHEBI:50692

subject_name: Mifepristone

object_name: ovarian cancer


subject: CHEBI:50692

object_name: ovarian neoplasm


subject: CHEBI:50692

object_name: ovarian carcinoma


subject: CHEBI:50692

object_name: fallopian tube carcinoma


subject: CHEBI:50692

object_name: fallopian tube cancer


subject: CHEBI:50692

object_name: peritoneum cancer


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: diverticulitis


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:6QVL057INT

object_name: cancer


subject: UNII:6QVL057INT

object_name: neoplasm


subject: UNII:6QVL057INT

object_name: Childhood Solid Neoplasm


subject: UNII:6QVL057INT

object_name: Adult Solid Neoplasm


subject: UNII:6QVL057INT

object_name: Solid Neoplasm


subject: UNII:6QVL057INT

object_name: Primary malignant neoplasm


subject: UNII:6QVL057INT

object_name: childhood malignant neoplasm


subject: UNII:6QVL057INT

object_name: Malignant obstetric neoplasm


subject: UNII:6QVL057INT

object_name: non-small cell lung carcinoma


subject: UNII:6QVL057INT

object_name: Disseminated Malignant Neoplasm


subject: UNII:6QVL057INT

object_name: Embolism, Tumor


subject: UNII:6QVL057INT

object_name: Neoplasm Metastasis


subject: UNII:6QVL057INT

object_name: head and neck squamous cell carcinoma


subject: UNII:6QVL057INT

object_name: leiomyosarcoma


subject: UNII:6QVL057INT

object_name: Childhood Leiomyosarcoma


subject: UNII:6QVL057INT

object_name: Adult Leiomyosarcoma


subject: UNII:6QVL057INT

object_name: adult liposarcoma


subject: UNII:6QVL057INT

object_name: liposarcoma


subject: UNII:6QVL057INT

object_name: pediatric liposarcoma


subject: UNII:6QVL057INT

object_name: melanoma


subject: UMLS:C4053601

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4053601

object_name: cancer


subject: UMLS:C4053601

object_name: neoplasm


subject: UMLS:C4053601

object_name: Childhood Solid Neoplasm


subject: UMLS:C4053601

object_name: Adult Solid Neoplasm


subject: UMLS:C4053601

object_name: Solid Neoplasm


subject: UMLS:C4053601

object_name: Primary malignant neoplasm


subject: UMLS:C4053601

object_name: childhood malignant neoplasm


subject: UMLS:C4053601

object_name: Malignant obstetric neoplasm


subject: UMLS:C4053601

object_name: non-small cell lung carcinoma


subject: UMLS:C4053601

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4053601

object_name: Embolism, Tumor


subject: UMLS:C4053601

object_name: Neoplasm Metastasis


subject: UMLS:C4053601

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4053601

object_name: leiomyosarcoma


subject: UMLS:C4053601

object_name: Childhood Leiomyosarcoma


subject: UMLS:C4053601

object_name: Adult Leiomyosarcoma


subject: UMLS:C4053601

object_name: adult liposarcoma


subject: UMLS:C4053601

object_name: liposarcoma


subject: UMLS:C4053601

object_name: pediatric liposarcoma


subject: UMLS:C4053601

object_name: melanoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:4672

object_name: cancer


subject: CHEBI:4672

object_name: neoplasm


subject: CHEBI:4672

object_name: Childhood Solid Neoplasm


subject: CHEBI:4672

object_name: Adult Solid Neoplasm


subject: CHEBI:4672

object_name: Solid Neoplasm


subject: CHEBI:4672

object_name: Primary malignant neoplasm


subject: CHEBI:4672

object_name: childhood malignant neoplasm


subject: CHEBI:4672

object_name: Malignant obstetric neoplasm


subject: CHEBI:4672

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:4672

object_name: Embolism, Tumor


subject: CHEBI:4672

object_name: Neoplasm Metastasis


subject: CHEBI:4672

object_name: head and neck squamous cell carcinoma


subject: CHEBI:4672

object_name: leiomyosarcoma


subject: CHEBI:4672

object_name: Childhood Leiomyosarcoma


subject: CHEBI:4672

object_name: Adult Leiomyosarcoma


subject: CHEBI:4672

object_name: adult liposarcoma


subject: CHEBI:4672

object_name: liposarcoma


subject: CHEBI:4672

object_name: pediatric liposarcoma


subject: CHEBI:4672

object_name: melanoma


subject: UMLS:C5666950

subject_name: Anti-CD163 Monoclonal Antibody OR2805

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5666950

object_name: cancer


subject: UMLS:C5666950

object_name: neoplasm


subject: UMLS:C5666950

object_name: Childhood Solid Neoplasm


subject: UMLS:C5666950

object_name: Adult Solid Neoplasm


subject: UMLS:C5666950

object_name: Solid Neoplasm


subject: UMLS:C5666950

object_name: Primary malignant neoplasm


subject: UMLS:C5666950

object_name: childhood malignant neoplasm


subject: UMLS:C5666950

object_name: Malignant obstetric neoplasm


subject: UMLS:C5666950

object_name: non-small cell lung carcinoma


subject: UMLS:C5666950

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5666950

object_name: Embolism, Tumor


subject: UMLS:C5666950

object_name: Neoplasm Metastasis


subject: UMLS:C5666950

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5666950

object_name: leiomyosarcoma


subject: UMLS:C5666950

object_name: Childhood Leiomyosarcoma


subject: UMLS:C5666950

object_name: Adult Leiomyosarcoma


subject: UMLS:C5666950

object_name: adult liposarcoma


subject: UMLS:C5666950

object_name: liposarcoma


subject: UMLS:C5666950

object_name: pediatric liposarcoma


subject: UMLS:C5666950

object_name: melanoma


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Blood Loss


subject: UMLS:C0016004

object_name: Hemorrhage


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: diabetes mellitus


subject: UNII:1C6V77QF41

object_name: type 1 diabetes mellitus 1


subject: UNII:1C6V77QF41

object_name: type 1 diabetes mellitus


subject: UNII:1C6V77QF41

object_name: Diabetes, Autoimmune


subject: UNII:1C6V77QF41

object_name: hypoglycemia


subject: UNII:1C6V77QF41

object_name: Blood glucose below reference range (finding)


subject: UNII:1C6V77QF41

object_name: Hypoglycemia, CTCAE


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: GTOPDB:12349

subject_name: zimberelimab

object_name: Childhood Solid Neoplasm


subject: GTOPDB:12349

object_name: Adult Solid Neoplasm


subject: GTOPDB:12349

object_name: Solid Neoplasm


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C3501748

subject_name: biphasic human insulin 30

object_name: type 2 diabetes mellitus


subject: UMLS:C3501748

object_name: Diabetes


subject: UMLS:C3501748


subject: UMLS:C3501748


subject: UMLS:C3501748


subject: CHEBI:5147

subject_name: Formoterol

object_name: asthma


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:64064

subject_name: Salmeterol


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:53477758

object_name: alcohol dependence


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:7915

subject_name: Pantoprazole


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: esophageal adenocarcinoma


subject: CHEBI:175901

object_name: lung adenocarcinoma


subject: CHEBI:175901

object_name: cervical adenocarcinoma


subject: CHEBI:175901

object_name: adenocarcinoma


subject: CHEBI:175901

object_name: bile duct adenocarcinoma


subject: CHEBI:175901

object_name: gastric adenocarcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C2826358


subject: UMLS:C2826358


subject: UMLS:C2826358


subject: UMLS:C2826358


subject: UMLS:C2826358


subject: UMLS:C2826358


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: psychosis


subject: CHEBI:31236

object_name: Nonorganic psychosis


subject: CHEBI:31236

object_name: Psychosis, CTCAE


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:8871


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: ulcerative colitis


subject: UNII:3XVL385Q0M

object_name: inflammatory bowel disease 1


subject: UNII:43OFW291R9

subject_name: TRIPTORELIN ACETATE

object_name: infertility


subject: UMLS:C0771825

subject_name: triptorelin acetate


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: postpartum hemorrhage


subject: MESH:D002136

object_name: Post-partum hemorrhage


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: PUBCHEM.COMPOUND:53477758


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Hypercholesterolemia


subject: CHEBI:49040

object_name: coronary artery disorder


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: exocrine pancreatic carcinoma


subject: CHEBI:175901

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:114785

subject_name: Erlotinib

object_name: pancreatic neoplasm


subject: CHEBI:114785


subject: CHEBI:114785


subject: HMDB:HMDB0248508

subject_name: Apelin

object_name: heart failure


subject: HMDB:HMDB0248508

object_name: Heart Failure, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4650373

subject_name: APELIN


subject: CHEMBL.COMPOUND:CHEMBL4650373


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: liver carcinoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:177451

subject_name: Fasiglifam

object_name: type 2 diabetes mellitus


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: endometrial cancer


subject: CHEBI:233362

object_name: uterine corpus cancer


subject: CHEBI:233362

object_name: endometrial carcinoma


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22

object_name: Crohn disease


subject: PR:000005931

object_name: inflammatory bowel disease 1


subject: PR:000005931


subject: CHEBI:15372

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:15372

object_name: COPD, severe early onset


subject: CHEBI:15372

object_name: chronic obstructive pulmonary disease


subject: CHEBI:15372

object_name: Increased reactive oxygen species production


subject: CHEBI:15372

object_name: hyperphenylalaninemia due to tetrahydrobiopterin deficiency


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: PUBCHEM.COMPOUND:129630809


subject: PUBCHEM.COMPOUND:129630809


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: CHEBI:59560


subject: CHEBI:59560


subject: CHEBI:59560


subject: CHEBI:229764

subject_name: Selinexor

object_name: prostate carcinoma


subject: CHEBI:229764

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: HIV infection


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: MESH:D008458

subject_name: Measles Vaccine


subject: MESH:D009108

subject_name: Mumps Vaccine


subject: UMLS:C0876134

subject_name: Prevnar


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine


subject: UMLS:C4330927


subject: UMLS:C4330927


subject: UMLS:C4330927

object_name: Recurrence


subject: UMLS:C4330927

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C4330927

object_name: Recurrent disease


subject: UMLS:C4330927

object_name: Recurrent tumor


subject: UMLS:C4330927

object_name: prostate neoplasm


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: CHEBI:47781

subject_name: Desipramine

object_name: cocaine abuse


subject: CHEBI:47781

object_name: substance-related disorder


subject: UMLS:C1696294

subject_name: Yaz

object_name: Uses contraception (finding)


subject: CHEBI:87631

subject_name: statin

object_name: Ischemic stroke


subject: CHEBI:9150

subject_name: Simvastatin


subject: UMLS:C4055621

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4055621

object_name: triple-negative breast carcinoma


subject: UMLS:C4055621

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4055621

object_name: non-small cell lung carcinoma


subject: UMLS:C4055621

object_name: glioblastoma


subject: UMLS:C4055621

object_name: Brain Stem Glioblastoma


subject: UMLS:C4055621

object_name: glioma susceptibility 1


subject: UMLS:C4055621

object_name: colorectal carcinoma


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Pancreatic Cyst


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Childhood Solid Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Adult Solid Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Solid Neoplasm


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:H1FKG90039

subject_name: TREPROSTINIL DIOLAMINE

object_name: Pulmonary hypertension due to left heart disease


subject: CHEBI:50861

subject_name: Treprostinil


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Cardiac iron overload


subject: CHEBI:49005

object_name: Elevated myocardial iron load


subject: CHEBI:4356

subject_name: Deferoxamine


subject: CHEBI:4356


subject: UMLS:C4745029

subject_name: HLX 10

object_name: Stomach cancer


subject: UMLS:C4745029

object_name: gastric cancer


subject: UMLS:C1815260

subject_name: Advate

object_name: hemophilia A


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: panuveitis


subject: UNII:BTY153760O

object_name: intermediate uveitis


subject: UNII:BTY153760O

object_name: anterior uveitis


subject: UNII:BTY153760O

object_name: posterior uveitis


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Dyssomnias


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:52717

subject_name: Bortezomib

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:52717

object_name: non-Hodgkin lymphoma


subject: CHEBI:52717

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:75984

subject_name: Flecainide

object_name: mitral valve prolapse


subject: CHEBI:75984

object_name: Ventricular arrhythmias and cardiac arrest


subject: CHEBI:133021

subject_name: Venetoclax

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:133021

object_name: acute myeloid leukemia


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:3641

subject_name: Chlorotrianisene

object_name: liver carcinoma


subject: UMLS:C0723595

subject_name: Tace


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17925

object_name: obesity


subject: CHEBI:17925

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:64220

subject_name: monosodium glutamate


subject: CHEBI:64220


subject: CHEBI:64220


subject: CHEBI:16015

subject_name: Glutamic acid


subject: CHEBI:16015


subject: CHEBI:16015


subject: UMLS:C0037511

subject_name: sodium glutamate


subject: UMLS:C0037511


subject: UMLS:C0037511


subject: UNII:7CS0WNO31M

subject_name: QUININE HYDROCHLORIDE


subject: UNII:7CS0WNO31M


subject: UNII:7CS0WNO31M


subject: CHEBI:137041


subject: CHEBI:137041


subject: CHEBI:137041


subject: CHEBI:15854

subject_name: Quinine


subject: CHEBI:15854


subject: CHEBI:15854


subject: UNII:8ZHS5657EH

subject_name: Tagraxofusp

object_name: CD4+/CD56+ hematodermic neoplasm


subject: UMLS:C1831974


subject: CHEBI:149504

object_name: kidney disorder


subject: CHEBI:149504

object_name: sickle cell disease


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:78855

subject_name: penicilloyl polylysine

object_name: airway disease


subject: CHEBI:78855

object_name: trachea carcinoma in situ


subject: CHEBI:78855

object_name: tracheal disorder


subject: CHEBI:78855

object_name: benign neoplasm of trachea


subject: CHEBI:78855

object_name: trachea findings


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:24993045

object_name: Chronic Kidney Disease, CTCAE


subject: PUBCHEM.COMPOUND:24993045

object_name: type 2 diabetes mellitus


subject: UMLS:C3529192


subject: UMLS:C3529192


subject: UMLS:C3529192


subject: CHEBI:45783

subject_name: Imatinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:J8435V445B

subject_name: Alicaforsen

object_name: pouchitis


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: end stage renal failure


subject: CHEBI:48390

object_name: Chronic uremia


subject: CHEBI:91327

subject_name: Tivozanib

object_name: renal cell carcinoma


subject: CHEBI:109549

subject_name: Ramelteon

object_name: REM sleep behavior disorder


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: Chronic small plaque psoriasis


subject: CHEBI:48390


subject: CHEBI:48390


subject: CHEBI:48390

object_name: secondary hyperparathyroidism


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: HIV infection


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: dry eye syndrome


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: B-cell neoplasm


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:67271

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:67271

object_name: Recurrent ovarian cancer


subject: CHEBI:67271

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:67271

object_name: ovarian sarcoma


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: hypogonadism, male


subject: PUBCHEM.COMPOUND:21873174

object_name: Klinefelter syndrome


subject: PUBCHEM.COMPOUND:21873174

object_name: primary ovarian failure


subject: PUBCHEM.COMPOUND:21873174

object_name: hypogonadotropic hypogonadism


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Childhood Solid Neoplasm


subject: CHEBI:231679

object_name: Adult Solid Neoplasm


subject: CHEBI:231679

object_name: Solid Neoplasm


subject: CHEBI:231679

object_name: neuroendocrine carcinoma


subject: CHEBI:231679

object_name: non-small cell lung carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Cystoid macular edema following cataract surgery


subject: UNII:15C2VL427D

object_name: Irvine-Gass Syndrome


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Double-Expressor Lymphoma


subject: CHEBI:4026

object_name: high grade B-cell lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888

object_name: diffuse large B-cell lymphoma


subject: CHEBI:6888

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:6888

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UNII:KG6VO684Z6


subject: UNII:KG6VO684Z6


subject: UNII:KG6VO684Z6


subject: UNII:KG6VO684Z6


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:3Q9L08K71N

subject_name: Evening primrose oil

object_name: Missed abortion


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: amoxicillin allergy


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: thrombocytopenia


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: inflammatory bowel disease


subject: UNII:B72HH48FLU

object_name: ulcerative colitis


subject: UMLS:C5417942

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C5417942

object_name: Lymphoma, Extranodal NK-T-Cell


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Blast Phase


subject: UNII:2S9ZZM9Q9V

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:94646

subject_name: Flupirtine

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: Advanced Bile Duct Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: narcolepsy


subject: CHEBI:30830

object_name: hypersomnia


subject: CHEBI:30830

object_name: Hypersomnia, CTCAE


subject: CHEBI:30830

object_name: traumatic encephalopathy


subject: CHEBI:30830

object_name: traumatic brain injury


subject: UMLS:C2745868

subject_name: TMC 435

object_name: hepatitis C


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: hairy cell leukemia


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:174615

object_name: plasma cell myeloma


subject: CHEBI:28901

subject_name: Busulfan


subject: GTOPDB:12889

subject_name: elranatamab


subject: UNII:L0HR9A577V

subject_name: Elranatamab


subject: UMLS:C4687515


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:125354

subject_name: Plerixafor


subject: UMLS:C5418100

subject_name: Davoceticept

object_name: adult lymphoma


subject: UMLS:C5418100

object_name: lymphoma


subject: UMLS:C5418100

object_name: pediatric lymphoma


subject: UMLS:C5418100

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: Psoriasis genital


subject: UNII:8G388563M7

subject_name: Telotristat ethyl

object_name: carcinoid heart disease


subject: UNII:8G388563M7

object_name: small intestine neuroendocrine tumor, well differentiated, low or intermediate grade


subject: CHEBI:5441

subject_name: Glyburide

object_name: gestational diabetes


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: skin disorder caused by infection


subject: UNII:6GNT3Y5LMF

object_name: skin infection


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: UMLS:C5667082

subject_name: Anti-HER3 Monoclonal Antibody SIBP-03

object_name: neoplasm


subject: UMLS:C5667082

object_name: Tumor Mass


subject: CHEBI:94480

subject_name: Lacidipine

object_name: hypertension


subject: CHEBI:94480

object_name: Hypertension, CTCAE


subject: CHEBI:36386

subject_name: Dichloroacetic acid

object_name: lactic acidosis


subject: CHEBI:8499

subject_name: Propranolol

object_name: primary lymphedema


subject: CHEBI:8499

object_name: lymphatic malformation


subject: CHEBI:8499

object_name: Milroy Disease


subject: CHEBI:8499

object_name: Primary lymphedema tardum


subject: CHEBI:8499

object_name: lymphatic malformation 5


subject: GTOPDB:13709

subject_name: olpasiran

object_name: kidney failure


subject: DRUGBANK:DB19001

subject_name: Olpasiran


subject: UMLS:C5237303

subject_name: CD11b Agonist GB1275

object_name: pancreatic adenocarcinoma


subject: UMLS:C5237303

object_name: gastric adenocarcinoma


subject: UMLS:C5237303

object_name: esophageal adenocarcinoma


subject: UMLS:C5237303

object_name: urothelial carcinoma


subject: UMLS:C5237303

object_name: transitional cell carcinoma


subject: UMLS:C5237303

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5237303

object_name: clear cell renal carcinoma


subject: UMLS:C5237303

object_name: renal cell adenocarcinoma


subject: UMLS:C5237303

object_name: renal cell carcinoma


subject: UMLS:C5237303


subject: UMLS:C5237303

object_name: liver carcinoma


subject: UMLS:C5237303

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5237303

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5237303

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5237303

object_name: triple-negative breast carcinoma


subject: UMLS:C5237303

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5237303

object_name: non-small cell lung carcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:135515

subject_name: Bendamustine

object_name: marginal zone lymphoma


subject: CHEBI:135515

object_name: MALT lymphoma


subject: CHEBI:18132

subject_name: phosphocholine

object_name: non-Hodgkin lymphoma


subject: CHEBI:18132


subject: CHEBI:18132


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: UniProtKB:Q62857


subject: UniProtKB:Q62857


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: PR:000006347


subject: PR:000006347


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:8Z28M5SX0X

subject_name: Zandelisib


subject: UNII:8Z28M5SX0X


subject: UNII:8Z28M5SX0X


subject: UNII:N8VKI8FPW0

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:N8VKI8FPW0


subject: UNII:N8VKI8FPW0

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:N8VKI8FPW0

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:N8VKI8FPW0

object_name: Myelodysplasia


subject: UNII:N8VKI8FPW0

object_name: Adult Solid Neoplasm


subject: UNII:N8VKI8FPW0

object_name: neoplasm


subject: CHEBI:135918

subject_name: Tucidinostat


subject: GTOPDB:10492

subject_name: envafolimab


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C5555581

subject_name: Inetetamab

object_name: Locally advanced breast cancer


subject: UMLS:C5555581

object_name: Effects of chemotherapy


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:131174

subject_name: Navitoclax

object_name: myelofibrosis


subject: UMLS:C1619357

subject_name: Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

object_name: multiple sclerosis


subject: UMLS:C1328149

object_name: renal cell carcinoma


subject: UMLS:C1328149

object_name: kidney neoplasm


subject: UMLS:C1328149

object_name: kidney cancer


subject: CHEBI:66910

subject_name: Axitinib


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: hypertension


subject: CHEBI:3127

object_name: Hypertension, CTCAE


subject: CHEBI:3441

subject_name: Carvedilol


subject: CHEBI:3441


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: melanoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:94366

subject_name: itraconazole

object_name: Alzheimer disease


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: frequent heartburn


subject: CHEBI:134722

subject_name: Favipiravir

object_name: influenza


subject: CHEBI:134722

object_name: Critical Illness


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: skin disorder


subject: UMLS:C3658854


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:LDJ89SS0YG

object_name: non-Hodgkin lymphoma


subject: UNII:LDJ89SS0YG

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UNII:KG6VO684Z6


subject: UNII:KG6VO684Z6


subject: UNII:KG6VO684Z6


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Arthritis of knee


subject: CHEBI:60802

object_name: osteoarthritis, knee


subject: CHEBI:60802

object_name: knee pain chronic


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Chronic small plaque psoriasis


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Diabetic foot ulcer


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Finding of lactation


subject: PUBCHEM.COMPOUND:158348

object_name: Ascites


subject: PUBCHEM.COMPOUND:158348

object_name: Ascites, CTCAE


subject: PUBCHEM.COMPOUND:158348

object_name: liver cirrhosis


subject: CHEMBL.COMPOUND:CHEMBL2107777

subject_name: SATAVAPTAN


subject: CHEMBL.COMPOUND:CHEMBL2107777


subject: CHEMBL.COMPOUND:CHEMBL2107777


subject: CHEBI:194402

subject_name: Satavaptan


subject: CHEBI:194402


subject: CHEBI:194402


subject: UMLS:C3530089


subject: UMLS:C3530089


subject: UMLS:C3530089


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Adverse drug response


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:32150

object_name: Calcinosis cutis


subject: CHEBI:132112


subject: CHEBI:15738

subject_name: Staurosporine


subject: MESH:D016324

subject_name: Sequence Tagged Sites


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)


subject: CHEBI:5931

subject_name: insulin human

object_name: diabetic ketoacidosis


subject: UMLS:C0876064

subject_name: Lantus


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Systemic inflammatory response


subject: PUBCHEM.COMPOUND:92043599

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:92043599

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:92043599

object_name: Coronary Occlusion


subject: PUBCHEM.COMPOUND:92043599

object_name: coronary stenosis


subject: PUBCHEM.COMPOUND:92043599

object_name: Epigenetic disorder


subject: PUBCHEM.COMPOUND:92043599

object_name: Hemorrhage


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: anemia


subject: CHEBI:81579

object_name: Anemia, CTCAE


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:135686

subject_name: Alvimopan

object_name: Constipation


subject: CHEBI:135686

object_name: Constipation, CTCAE


subject: CHEBI:135686

object_name: cancer


subject: CHEBI:135686

object_name: neoplasm


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: lung cancer


subject: UNII:M487QF2F4V

object_name: lung neoplasm


subject: UNII:M487QF2F4V

object_name: lung carcinoma


subject: UNII:M487QF2F4V

object_name: Radiation Sickness


subject: UNII:M487QF2F4V

object_name: Drug toxicity


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:6504

object_name: spinal cord injury


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Intraoperative Hemorrhage


subject: CHEBI:8988

object_name: Stomach cancer


subject: CHEBI:8988

object_name: gastric cancer


subject: CHEBI:8988

object_name: esophageal adenocarcinoma


subject: CHEBI:8988

object_name: lung adenocarcinoma


subject: CHEBI:8988

object_name: cervical adenocarcinoma


subject: CHEBI:8988

object_name: adenocarcinoma


subject: CHEBI:8988

object_name: bile duct adenocarcinoma


subject: CHEBI:8988

object_name: gastric adenocarcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:57858

subject_name: atropinium

object_name: Drooling


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:5494

subject_name: ritropirronium bromide


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: pelvic organ prolapse


subject: CHEBI:133351

subject_name: hydantoic acid

object_name: Verruca plana


subject: CHEBI:133351

object_name: HIV infection


subject: CHEBI:17497

subject_name: Glycolic acid


subject: CHEBI:17497


subject: CHEBI:8080

subject_name: Phentermine

object_name: type 2 diabetes mellitus


subject: CHEBI:8080

object_name: Diabetes


subject: CHEBI:8080

object_name: diabetes mellitus


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:63631


subject: CHEBI:63631


subject: UNII:E569WG6E60

subject_name: Arzoxifene

object_name: endometrial cancer


subject: UNII:E569WG6E60

object_name: uterine corpus cancer


subject: UNII:E569WG6E60

object_name: endometrial carcinoma


subject: UNII:E569WG6E60

object_name: Childhood Breast Carcinoma


subject: UNII:E569WG6E60

object_name: breast carcinoma


subject: UNII:E569WG6E60

object_name: breast cancer


subject: UNII:E569WG6E60

object_name: ovarian cancer


subject: UNII:E569WG6E60

object_name: ovarian neoplasm


subject: UNII:E569WG6E60

object_name: ovarian carcinoma


subject: UMLS:C1831852

subject_name: Lanreotide Long-Acting Aqueous Gel

object_name: acromegaly


subject: UMLS:C1831852

object_name: Acral overgrowth


subject: CHEBI:135901

subject_name: lanreotide


subject: CHEBI:135901


subject: UNII:IEU56G3J9C

subject_name: LANREOTIDE ACETATE


subject: UNII:IEU56G3J9C


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Substance Use Disorders


subject: CHEBI:8707

object_name: Dependence


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:3387

subject_name: Carbamazepine


subject: CHEBI:3387


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:9123


subject: CHEBI:2666

subject_name: Amitriptyline


subject: CHEBI:2666


subject: UNII:T60AV22R32

subject_name: Chlorazine


subject: UNII:T60AV22R32


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:3647


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: UMLS:C2355616

subject_name: highly purified urofollitropin

object_name: infertility


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: healthy, no evidence of disease


subject: MESH:C000614959

object_name: thyroid gland carcinoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: concussion


subject: CHEBI:46195

object_name: Headache


subject: CHEBI:46195

object_name: Headache, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: kidney failure


subject: CHEBI:74947

subject_name: Thalidomide

object_name: plasma cell myeloma


subject: UNII:HU43305R7O

object_name: prostate carcinoma


subject: UNII:HU43305R7O

object_name: prostate cancer


subject: UNII:2C4Y86R2AX


subject: UNII:2C4Y86R2AX


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: multiple organ dysfunction syndrome


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:155543961

object_name: Diabetes


subject: PUBCHEM.COMPOUND:155543961

object_name: diabetes mellitus


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UNII:1ER2O3UZ4W


subject: UNII:1ER2O3UZ4W


subject: UNII:1ER2O3UZ4W

object_name: esophageal cancer


subject: UNII:1ER2O3UZ4W

object_name: pancreatic neoplasm


subject: UNII:1ER2O3UZ4W

object_name: exocrine pancreatic carcinoma


subject: UNII:1ER2O3UZ4W

object_name: malignant pancreatic neoplasm


subject: UNII:1ER2O3UZ4W

object_name: Childhood Breast Carcinoma


subject: UNII:1ER2O3UZ4W

object_name: breast carcinoma


subject: UNII:1ER2O3UZ4W

object_name: breast cancer


subject: UNII:1ER2O3UZ4W

object_name: liver cancer


subject: UNII:1ER2O3UZ4W

object_name: liver neoplasm


subject: UNII:1ER2O3UZ4W

object_name: Adult Liver Carcinoma


subject: UNII:1ER2O3UZ4W

object_name: liver carcinoma


subject: UNII:1ER2O3UZ4W

object_name: ovarian cancer


subject: UNII:1ER2O3UZ4W

object_name: ovarian neoplasm


subject: UNII:1ER2O3UZ4W

object_name: colon carcinoma


subject: UNII:1ER2O3UZ4W

object_name: colorectal cancer


subject: UNII:1ER2O3UZ4W

object_name: colon cancer


subject: UNII:1ER2O3UZ4W

object_name: lung cancer


subject: UNII:1ER2O3UZ4W

object_name: lung neoplasm


subject: UNII:1ER2O3UZ4W

object_name: lung carcinoma


subject: CHEBI:16919

subject_name: Creatine

object_name: osteoarthritis, knee


subject: UMLS:C0295415

subject_name: rituximab

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: spinal cord injury


subject: CHEBI:2567

object_name: Osteopenia


subject: CHEBI:2567

object_name: osteoporosis


subject: CHEBI:2567

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:2567

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:2567

object_name: Osteoporosis, CTCAE 3.0


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: MESH:D002136


subject: MESH:D002136


subject: MESH:D002136


subject: MESH:D002136


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C0358506

subject_name: Sodium bicarbonate I.V.

object_name: acute kidney failure


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: UNII:M89N0Q7EQR

object_name: High-Grade Squamous Intraepithelial Lesions


subject: PR:000001379


subject: PR:000001379


subject: PR:000015975

subject_name: sperm motility kinase Tcr mutant form


subject: PR:000015975


subject: UMLS:C0034790

subject_name: T-Cell Receptor


subject: UMLS:C0034790


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: herpes zoster


subject: PUBCHEM.COMPOUND:4715169

object_name: postherpetic neuralgia


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Depth of anesthesia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:36791

subject_name: Escitalopram

object_name: atypical depressive disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3219

subject_name: Bupropion

object_name: major depressive disorder


subject: CHEBI:3219

object_name: endogenous depression


subject: CHEBI:36796

subject_name: duloxetine


subject: CHEBI:36796


subject: CHEBI:36791


subject: CHEBI:3723


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: plasma cell myeloma


subject: UMLS:C1709429


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:52717

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:52717

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:52717

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:52717

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:52717

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:52717

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:52717

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:52717

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:52717

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:52717

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:52717

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:73945175

subject_name: Implitapide

object_name: hypertriglyceridemia


subject: PUBCHEM.COMPOUND:73945175

object_name: Hypertriglyceridemia, CTCAE


subject: PUBCHEM.COMPOUND:23582788

subject_name: Tegoprazan

object_name: Helicobacter pylori infection


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Carcinoma breast stage IV


subject: CHEBI:68575

subject_name: Indacaterol

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:68575

object_name: COPD, severe early onset


subject: CHEBI:68575

object_name: obstructive lung disease


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: postmenopausal osteoporosis


subject: CHEBI:2567

subject_name: Alendronic acid


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:6801

subject_name: Metformin

object_name: Childhood Breast Carcinoma


subject: CHEBI:6801

object_name: breast carcinoma


subject: CHEBI:6801

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: ST-elevation myocardial infarction


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: ST Elevation Myocardial Infarction


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: age


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: CHEBI:59173


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:2767

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Post-Operative Pain


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:76668718

subject_name: Pibrentasvir


subject: PUBCHEM.COMPOUND:14586216

subject_name: Prunus inhibitor b


subject: CHEBI:53725

subject_name: poly(isobutylene)


subject: CHEBI:1457

subject_name: Tramiprosate

object_name: Alzheimer disease


subject: UMLS:C0062961

subject_name: tramiprosate


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:1805

object_name: acute myeloid leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:81569

subject_name: Follitropin

object_name: Androgen excess


subject: CHEBI:6413

subject_name: Letrozole

object_name: Childhood Breast Carcinoma


subject: CHEBI:6413

object_name: breast carcinoma


subject: CHEBI:6413

object_name: breast cancer


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: MESH:D000086663

subject_name: COVID-19 Vaccines


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: PUBCHEM.COMPOUND:544190

object_name: heart failure


subject: PUBCHEM.COMPOUND:544190

object_name: Heart Failure, CTCAE


subject: CHEBI:7798

subject_name: Oseltamivir


subject: CHEBI:7798


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Prader-Willi syndrome


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:5HRZ7WFW3T

object_name: non-small cell lung carcinoma


subject: UNII:5HRZ7WFW3T


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: Pulmonary embolism and thrombosis


subject: RXCUI:1999667

subject_name: bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet

object_name: HIV infection


subject: UNII:K911R84KEW

subject_name: Margetuximab


subject: UNII:K911R84KEW


subject: UNII:K911R84KEW


subject: UMLS:C2984521

subject_name: MGAH22 antibody


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: CHEBI:3223

subject_name: Buspirone

object_name: Heartburn


subject: CHEBI:8871

subject_name: Risperidone


subject: PUBCHEM.COMPOUND:122316

object_name: Parkinson disease


subject: CHEBI:63620

subject_name: Rasagiline


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: MESH:D002136

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: CHEBI:28976

subject_name: carbonic acid


subject: CHEBI:28976


subject: CHEBI:46721

subject_name: carbonate salt


subject: CHEBI:46721


subject: CHEBI:41609

subject_name: Carbonate ion


subject: CHEBI:41609


subject: CHEBI:39112

subject_name: Bosutinib

object_name: mild neurocognitive disorder


subject: CHEBI:39112

object_name: mild cognitive impairment


subject: CHEBI:39112

object_name: Presenile dementia


subject: CHEBI:39112

object_name: dementia


subject: CHEBI:50838

subject_name: Drospirenone

object_name: autosomal dominant polycystic kidney disease


subject: PR:000012938

subject_name: pinin


subject: CHEBI:5390

subject_name: Glu-Glu


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:7627

subject_name: Norethisterone


subject: PUBCHEM.COMPOUND:152274851

object_name: hepatitis


subject: PUBCHEM.COMPOUND:152274851

object_name: Chronic hepatitis


subject: UNII:MHY5H5WMW6


subject: UNII:MHY5H5WMW6


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: age-related macular degeneration


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: generalized anxiety disorder


subject: CHEBI:52993

object_name: anxiety disorder


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:177450

subject_name: Bardoxolone

object_name: adult lymphoma


subject: CHEBI:177450

object_name: lymphoma


subject: CHEBI:177450

object_name: pediatric lymphoma


subject: CHEBI:177450

object_name: Solid Neoplasm


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: Hyperkalemia, CTCAE


subject: UNII:D652ZWF066

object_name: Hyperkalemia


subject: CHEBI:10650

subject_name: Sumatriptan

object_name: migraine


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Childhood Breast Carcinoma


subject: CHEBI:230905

object_name: breast carcinoma


subject: CHEBI:230905

object_name: breast cancer


subject: CHEBI:66910

subject_name: Axitinib

object_name: melanoma


subject: CHEBI:66910

object_name: stage IIIB melanoma


subject: CHEBI:66910

object_name: stage IIIA melanoma


subject: CHEBI:66910

object_name: stage IIIC melanoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: marginal zone lymphoma


subject: CHEBI:52717

object_name: MALT lymphoma


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717

object_name: follicular lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026

object_name: adult lymphoma


subject: CHEBI:4026

object_name: lymphoma


subject: CHEBI:4026

object_name: pediatric lymphoma


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:31300

object_name: pulmonary hypertension


subject: CHEBI:31300

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:31300

object_name: pulmonary arterial hypertension


subject: CHEBI:31300

object_name: Vasodilation disorder


subject: CHEBI:31300

object_name: Pathologic vasoconstriction


subject: CHEBI:31300

object_name: Vasoconstriction


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:135736

subject_name: Sitaxentan


subject: CHEBI:135736


subject: CHEBI:135736


subject: CHEBI:135736


subject: CHEBI:135736


subject: CHEBI:135736


subject: CHEBI:135736


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Childhood Glioblastoma


subject: UMLS:C0919079

object_name: adult glioblastoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C4329512

subject_name: UCPVax

object_name: glioblastoma


subject: UMLS:C4329512


subject: UMLS:C4329512


subject: GTOPDB:8407

subject_name: etrolizumab

object_name: inflammatory bowel disease 1


subject: GTOPDB:8407

object_name: Crohn disease


subject: CHEMBL.COMPOUND:CHEMBL1743015

subject_name: ETROLIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743015


subject: UMLS:C3177463


subject: UMLS:C3177463


subject: CHEBI:4672

subject_name: Docetaxel

object_name: pancreatic neoplasm


subject: CHEBI:4672

object_name: exocrine pancreatic carcinoma


subject: CHEBI:4672

object_name: malignant pancreatic neoplasm


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: CHEBI:151315


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:995FT1W541

subject_name: Idronoxil

object_name: prostate carcinoma


subject: UNII:995FT1W541

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Opioid withdrawal


subject: PUBCHEM.COMPOUND:9848990

object_name: opiate dependence


subject: UNII:F70C5K4786

subject_name: Melphalan flufenamide

object_name: plasma cell myeloma


subject: UNII:3412470A0V

subject_name: melflufen


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Osteopenia


subject: CHEBI:23965

subject_name: estradiol

object_name: post-traumatic stress disorder


subject: CHEBI:23965

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Immediate Postpartum Hemorrhage


subject: CHEBI:9123

subject_name: Sertraline

object_name: anxiety


subject: CHEBI:9123

object_name: anxiety disorder


subject: CHEBI:9123

object_name: Anxiety symptoms


subject: CHEBI:9123

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:9123

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:44241

subject_name: Metyrapone

object_name: Depressed mood


subject: CHEBI:44241

object_name: Cancer patients and suicide and depression


subject: CHEBI:44241

object_name: Depressed - symptom


subject: CHEBI:44241

object_name: Depression, CTCAE


subject: CHEBI:29033

subject_name: Ferrous cation


subject: CHEBI:29033


subject: CHEBI:29033


subject: CHEBI:29033


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: nonpapillary renal cell carcinoma


subject: UNII:28X28X9OKV

object_name: clear cell renal carcinoma


subject: UNII:28X28X9OKV

object_name: renal carcinoma


subject: UNII:28X28X9OKV

object_name: kidney neoplasm


subject: UNII:28X28X9OKV

object_name: kidney cancer


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C4053618


subject: UMLS:C4053618


subject: UMLS:C4053618


subject: UMLS:C4053618


subject: UMLS:C4053618


subject: CHEBI:95165

object_name: Refractory acute myeloid leukemia


subject: CHEBI:95165

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: DRUGBANK:DB16630

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB16630

object_name: acute myeloid leukemia


subject: DRUGBANK:DB16630


subject: DRUGBANK:DB16630


subject: UMLS:C3896906

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:596

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:596

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:596

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:596

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:596

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:596

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:596

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:596

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:596

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:596

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Adult Acute Basophilic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Adult Acute Eosinophilic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: refractory anemia with excess blasts in transformation


subject: PUBCHEM.COMPOUND:596

object_name: Adult Erythroleukemia


subject: CHEBI:28680

subject_name: Cytarabine

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:28680

object_name: chronic myelomonocytic leukemia


subject: CHEBI:28680

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:28680

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28680

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:28680

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:28680

object_name: Secondary Myelodysplastic Syndrome